Cleveland Clinic Taussig Cancer Institute

Taussig Cancer Institute is the hub for Cleveland Clinic Cancer Center.


 

Cleveland Clinic’s Update on Genomics in mCRC: How Does Pembro Affect PFS/OS? Is Encorafenib/Cetuximab/Binimetinib Beneficial for BRAF V600E Mutations? Should We Use Trastuzumab in Different Combinations for HER2+ Disease?

103 views
November 26, 2020
Comments 0
Login to view comments. Click here to Login